Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsORALStandard

GRISEOFULVIN, ULTRAMICROSIZE

GRISEOFULVIN, ULTRAMICROSIZE

Standard Dose
125MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription

Key Takeaways

  • Primary indication: Review priority: STANDARD Marketing status: Prescription
  • Approval overview GRISEOFULVIN, ULTRAMICROSIZE is listed in Drugs@FDA under application 204371 (ANDA).
  • Review priority: STANDARD Marketing status: Prescription Active ingredient GRISEOFULVIN, ULTRAMICROSIZE Form and strength TABLET;ORAL - 125MG Sponsor MOUNTAIN Submission history Latest submission status date: 2025-03-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview GRISEOFULVIN, ULTRAMICROSIZE is listed in Drugs@FDA under application 204371 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient GRISEOFULVIN, ULTRAMICROSIZE Form and strength TABLET;ORAL - 125MG Sponsor MOUNTAIN Submission history Latest submission status date: 2025-03-20 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.